CTSO
Cytosorbents Corp
Price:  
1.26 
USD
Volume:  
210,583.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CTSO EV/EBITDA

-490.0%
Upside

As of 2025-06-24, the EV/EBITDA ratio of Cytosorbents Corp (CTSO) is -5.94. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CTSO's latest enterprise value is 81.49 mil USD. CTSO's TTM EBITDA according to its financial statements is -13.73 mil USD. Dividing these 2 quantities gives us the above CTSO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 19.6x - 23.1x 21.5x
Forward P/E multiples 22.6x - 23.4x 23.0x
Fair Price (5.00) - (5.10) (4.91)
Upside -496.9% - -504.9% -490.0%
1.26 USD
Stock Price
(4.91) USD
Fair Price

CTSO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-11 -5.16
2025-06-10 -5.02
2025-06-09 -5.12
2025-06-06 -5.02
2025-06-05 -4.98
2025-06-04 -4.75
2025-06-03 -4.75
2025-06-02 -4.10
2025-05-30 -4.02
2025-05-29 -3.93
2025-05-28 -4.02
2025-05-27 -3.93
2025-05-23 -4.04
2025-05-22 -4.06
2025-05-21 -4.16
2025-05-20 -4.02
2025-05-19 -4.07
2025-05-16 -4.29
2025-05-15 -4.00
2025-05-14 -3.88
2025-05-13 -4.16
2025-05-12 -4.16
2025-05-09 -4.16
2025-05-08 -4.16
2025-05-07 -4.22
2025-05-06 -4.25
2025-05-05 -4.33
2025-05-02 -4.48
2025-05-01 -4.80
2025-04-30 -4.80
2025-04-29 -5.30
2025-04-28 -5.16
2025-04-25 -5.21
2025-04-24 -5.48
2025-04-23 -5.07
2025-04-22 -5.21
2025-04-21 -5.16
2025-04-17 -4.89
2025-04-16 -4.84
2025-04-15 -4.80
2025-04-14 -4.71
2025-04-11 -4.62
2025-04-10 -4.48
2025-04-09 -4.48
2025-04-08 -4.57
2025-04-07 -4.71
2025-04-04 -4.61
2025-04-03 -4.71
2025-04-02 -4.75
2025-04-01 -4.75